We are live on
!
Find out more
PVAM
Pacific View Asset Management Portfolio holdings
AUM
$20.8M
1-Year Est. Return
20.08%
This Fund
S&P 500
This Quarter
Est. Return
-18.97%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.1M
AUM Growth
-$40.6M
(-32%)
Cap. Flow
-$18.9M
Cap. Flow
% of AUM
-22.17%
Top 10 Holdings %
Top 10 Hldgs %
50.85%
Holding
93
New
6
Increased
24
Reduced
14
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$3.1M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$2.54M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$2.48M |
| 4 |
HIL
Hill International, Inc. Common Stock
HIL
|
+$2.42M |
| 5 |
Ameris Bancorp
ABCB
|
+$1.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global X Uranium ETF
URA
|
+$4.18M |
| 2 |
Limbach Holdings
LMB
|
+$4.17M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$3.16M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$2.98M |
| 5 |
Healthcare Services Group
HCSG
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.07% |
| 2 | Financials | 16.37% |
| 3 | Healthcare | 13.83% |
| 4 | Technology | 11.41% |
| 5 | Consumer Staples | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
51
DELISTED
Blueprint Medicines
BPMC
| $264K | 0.31% |
4,925
+193
| +4% | +$11.7K |
|
|
KYNB
52
Kyntra Bio
KYNB
$28.2M
| $243K | 0.29% |
211
+54
| +34% | +$60.7K |
|
|
FOLD
53
DELISTED
Amicus Therapeutics
FOLD
| $207K | 0.24% |
21,585
+497
| +2% | +$5.46K |
|
54
Silicon Laboratories
SLAB
$7.17B
| $207K | 0.24% |
2,608
| – | – |
|
|
EFOR
55
Everforth Inc
EFOR
$974M
| $200K | 0.24% |
3,679
| – | – |
|
56
Allient
ALNT
$1.35B
| – | – |
-20,441
| Closed | -$742K |
|
57
AnaptysBio
ANAB
$1.52B
| – | – |
-2,470
| Closed | -$245K |
|
58
Accuray
ARAY
$28.1M
| – | – |
-100,950
| Closed | -$454K |
|
59
Azenta
AZTA
$1.3B
| – | – |
-21,235
| Closed | -$744K |
|
60
Cognex
CGNX
$9.64B
| – | – |
-13,040
| Closed | -$728K |
|
61
Ciena
CIEN
$47.4B
| – | – |
-14,640
| Closed | -$454K |
|
62
EastGroup Properties
EGP
$11.1B
| – | – |
-6,423
| Closed | -$614K |
|
63
Globus Medical
GMED
$10.9B
| – | – |
-11,975
| Closed | -$680K |
|
64
IBM
IBM
$213B
| – | – |
-5,381
| Closed | -$778K |
|
65
Installed Building Products
IBP
$6.23B
| – | – |
-7,405
| Closed | -$287K |
|
|
IRBT
66
DELISTED
iRobot
IRBT
| – | – |
-6,380
| Closed | -$701K |
|
67
Intuitive Surgical
ISRG
$128B
| – | – |
-5,556
| Closed | -$1.06M |
|
68
J&J Snack Foods
JJSF
$1.51B
| – | – |
-2,708
| Closed | -$409K |
|
|
69
Limbach Holdings
LMB
$826M
| – | – |
-369,604
| Closed | -$4.17M |
|
70
Louisiana-Pacific
LPX
$5.16B
| – | – |
-8,887
| Closed | -$237K |
|
71
Natural Alternatives International
NAII
$14.9M
| – | – |
-88,165
| Closed | -$864K |
|
72
Novanta
NOVT
$4.89B
| – | – |
-9,813
| Closed | -$671K |
|
73
Nexstar Media Group
NXST
$5.96B
| – | – |
-12,341
| Closed | -$1M |
|
74
Omnicell
OMCL
$1.93B
| – | – |
-12,338
| Closed | -$887K |
|
75
Dave & Buster's
PLAY
$358M
| – | – |
-4,578
| Closed | -$302K |
|
Similar funds
CIM
ICP
QI
HWM
AGU
PCP
MAU
FCG
Pacific View Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Pacific View Asset Management held 93 positions worth $85.1M, down 32% from $126M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Pacific View Asset Management withdrew a net $18.9M in Q4 2018, closing 38 positions and reducing 14 holdings. Its most notable exit was Global X Uranium ETF, an estimated $4.18M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Pacific View Asset Management opened a new position in Hill International, Inc. Common Stock worth $2.34M.
- Pacific View Asset Management's largest Q4 2018 buy was Hill International, Inc. Common Stock: 760,000 shares worth $2.34M.
- Pacific View Asset Management added most to Proofpoint, Inc. in Q4 2018, an estimated $3.1M increase.
- Pacific View Asset Management's biggest Q4 2018 reduction was Array Biopharma Inc, cutting an estimated $3.16M.
- Pacific View Asset Management fully exited Global X Uranium ETF in Q4 2018, selling an estimated $4.18M.
- Pacific View Asset Management's ten largest holdings make up 51% of its $85.1M portfolio in Q4 2018.
- Pacific View Asset Management opened 6 new positions and closed 38 in Q4 2018.
- Pacific View Asset Management's portfolio value fell 32% quarter-over-quarter to $85.1M.
Based on Pacific View Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.